Comparison of the super agonist complex, ALT-803, to IL-15 as cancer immunotherapeutics in animal models

समान संसाधन

• A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
  द्वारा: Liu, Bai, और अन्य
  प्रकाशित: (2016)
• Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models
  द्वारा: Liu, Bai, और अन्य
  प्रकाशित: (2018)
• Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model
  द्वारा: Chen, Xiaoyue, और अन्य
  प्रकाशित: (2015)
• Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
  द्वारा: Xu, Wenxin, और अन्य
  प्रकाशित: (2015)
• Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
  द्वारा: Xu, Wenxin, और अन्य
  प्रकाशित: (2014)